©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Table 3 Studies showing therapeutic role of enteric nervous system on gastrointestinal motility disorders
| No. | Ref. | Study characteristics | Key role of ENS |
| 1 | Bessard et al[112] | Investigates alterations in prostanoid expression and intestinal epithelial barrier functions that contribute to ileus | Highlights how disruptions in ENS signaling and epithelial function lead to impaired motility and ileus development |
| 2 | Bonaz[113] | Discusses the role of enteric neuropathy and the vagus nerve in gastrointestinal disorders, with therapeutic implications | Explores how enteric neuropathy and vagal signaling impact gut function, offering insights into treatment strategies |
| 3 | Brun et al[114] | Studies how Toll-like receptor-2 regulates glial-derived neurotrophic factor production in intestinal smooth muscle cells | Focuses on how glial cells in the ENS influence smooth muscle function and gut motility via neurotrophic factor production |
| 4 | Ferreira-Duarte et al[115] | Explores the interaction between the renin-angiotensin system and enteric neurotransmission in colonic dysmotility in TNBS-induced colitis | Highlights the interplay between systemic signaling and the ENS, leading to dysmotility in inflammatory conditions like colitis |
| 5 | Filpa et al[116] | Investigates the role of glutamatergic neurotransmission in the ENS and its role in the brain-gut axis in health and disease | Explores how glutamate signaling in the ENS influences gut-brain communication and impacts gastrointestinal disorders |
| 6 | Floettmann et al[117] | Provides the pharmacological profile of Naloxegol, a peripherally acting μ-opioid receptor antagonist for opioid-induced constipation | Focuses on the interaction between opioid receptors in the ENS and peripheral opioid antagonism to treat constipation |
| 7 | Gao et al[118] | Investigates μ-opioid receptor-mediated enteric glial activation in morphine-induced constipation | Highlights the activation of enteric glia through opioid receptors, contributing to constipation in opioid use |
| 8 | Sanger et al[119] | Discusses the role of ghrelin and motilin control systems in gastrointestinal physiology and therapeutics | Explores the control of gastrointestinal motility via ghrelin and motilin systems, which interact with the ENS for motility regulation |
| 9 | Stakenborg et al[120] | Reviews pathophysiology and current therapeutic approaches to postoperative ileus | Discusses how the ENS is involved in the pathophysiology of ileus and how therapies targeting ENS dysfunction can improve recovery |
- Citation: Agrawal H, Agarwal N, Gupta N. Enteric nervous system as a therapeutic target in gastrointestinal disorders. World J Gastrointest Pharmacol Ther 2025; 16(4): 110843
- URL: https://www.wjgnet.com/2150-5349/full/v16/i4/110843.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.110843